FDA expands clearance for NuVasive small interlock cervical spine system — 3 insights

Spinal Tech

The FDA expanded its clearance for NuVasive's CoRoent Small Interlock system to allow for on-label use of the device at multiple contiguous spinal levels.

What you should know:

1. The device can now be used for levels from C2-T1 in both anterior cervical discectomy and fusion procedures.

2. The clearance differentiates Nuvasive's offering from other systems on the market that are only cleared for one- or two-level use.

3. NuVasive President Matt Link said the clearance is indicative of the company's work to deepen its presence in the cervical market and deliver proper solutions.

Leonel Hunt, MD, an orthopedic spine surgeon at Los Angeles-based Hunt Spine, said, "The multilevel clearance provides surgeons a zero-profile interbody implant that can be used in more than two contiguous levels, enabling the surgeon to avoid supplemental fixation which can ultimately reduce operative time."

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers